Thus, we evaluated the positive agreement of combined VIDAS® NS1/IgM and IgM/IgG test results in the total population and at relevant infection stages, i.e., acute stage for NS1/IgM and post-acute stage for IgM/IgG (Table 11). This evidence concerns the gene CD40LG and infection.